Presented by Boston Scientific

This webinar is the sole content of the Industry Sponsor and does not constitute an endorsement by the SVS or SVS Foundation for any products or therapies.

Description
This session will highlight the latest clinical evidence on the Eluvia Drug-Eluting Stent (DES), including insights from the SPORTS RCT, Eluvia Pooled Meta-Analysis, and Eluvia TRUE-PTX data. Faculty experts will discuss how these findings reinforce Eluvia’s advantages over alternative modalities—particularly in treating long, challenging lesions. Through case-based discussions and interactive dialogue, participants will gain practical strategies for integrating DES therapy into real-world practice and comparing its role to DCB and BMS approaches.

Key Topics

• Clinical data reinforcing Eluvia DES effectiveness
• Case insights on long, complex lesions
• DES vs. DCB/BMS in decision-making
• Real-world outcomes: reduced amputations and re-hospitalizations
• Impact on patient quality of life and hospital economics

Speakers
Dr. Anahita Dua - Massachusetts General Hospital
Dr. Sonya Noor - Buffalo General Medical Center
Dr. Peter Schneider - University of California, San Francisco

Target Audience
Vascular Surgeon
Vascular Trainee
General Surgery Residents
Medical Students
Other types of Physicians
Vascular Nurses
Vascular Technologists
Physician Assistants
Nurse Practitioners
Hospital and Practice Administrators

This video is part of the Vascular Innovations Webinar Series